Phase
Condition
Vision Loss
Eye Disease
Healthy Volunteers
Treatment
N/AClinical Study ID
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria (Test Group):
Had been diagnosed with keratoconus in at least one eye.
Is at least 18 years of age and has full legal capacity to volunteer.
Has read and understood the information consent letter.
Is willing and able to follow instructions and maintain the appointment schedule.
Inclusion Criteria (Control Group)
Had been NOT diagnosed with keratoconus in at least one eye.
Is at least 18 years of age and has full legal capacity to volunteer.
Has read and understood the information consent letter.
Is willing and able to follow instructions and maintain the appointment schedule.
Exclusion Criteria (Test Group):
Is using any topical medications that will affect ocular health.
Has any ocular pathology or severe insufficiency of lacrimal secretion (severe dry eyes) that would affect the wearing of contact lenses.
Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
Has any clinically significant lid or conjunctival abnormalities and active neovascularization.
Is aphakic.
Has undergone penetrating keratoplasty.
Is participating in any other type of eye related clinical or research study.
Has any known allergies or sensitivity to the diagnostic pharmaceuticals or products, such as fluorescein, used in this study.
Exclusion Criteria (Control Group):
Is using any topical medications that will affect ocular health.
Has any ocular pathology or severe insufficiency of lacrimal secretion (severe dry eyes) that would affect the wearing of contact lenses.
Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
Has any clinically significant lid or conjunctival abnormalities and active neovascularization.
Is aphakic.
Has undergone any corneal surgery.
Is participating in any other type of eye related clinical or research study.
Has any known allergies or sensitivity to the diagnostic pharmaceuticals or products, such as fluorescein, used in this study.
Study Design
Study Description
Connect with a study center
University of Waterloo School of Optometry and Vision Science
Waterloo, Ontario N2L3G1
CanadaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.